1. Home
  2. MBIO vs JTAI Comparison

MBIO vs JTAI Comparison

Compare MBIO & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • JTAI
  • Stock Information
  • Founded
  • MBIO 2015
  • JTAI 2018
  • Country
  • MBIO United States
  • JTAI United States
  • Employees
  • MBIO N/A
  • JTAI N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • JTAI Blank Checks
  • Sector
  • MBIO Health Care
  • JTAI Finance
  • Exchange
  • MBIO Nasdaq
  • JTAI Nasdaq
  • Market Cap
  • MBIO 7.3M
  • JTAI 7.1M
  • IPO Year
  • MBIO N/A
  • JTAI N/A
  • Fundamental
  • Price
  • MBIO $2.80
  • JTAI $6.03
  • Analyst Decision
  • MBIO Strong Buy
  • JTAI
  • Analyst Count
  • MBIO 1
  • JTAI 0
  • Target Price
  • MBIO $100.00
  • JTAI N/A
  • AVG Volume (30 Days)
  • MBIO 412.6K
  • JTAI 137.0K
  • Earning Date
  • MBIO 03-10-2025
  • JTAI 03-31-2025
  • Dividend Yield
  • MBIO N/A
  • JTAI N/A
  • EPS Growth
  • MBIO N/A
  • JTAI N/A
  • EPS
  • MBIO N/A
  • JTAI N/A
  • Revenue
  • MBIO N/A
  • JTAI $15,028,926.00
  • Revenue This Year
  • MBIO N/A
  • JTAI $21.49
  • Revenue Next Year
  • MBIO N/A
  • JTAI $10.05
  • P/E Ratio
  • MBIO N/A
  • JTAI N/A
  • Revenue Growth
  • MBIO N/A
  • JTAI 46.66
  • 52 Week Low
  • MBIO $2.40
  • JTAI $2.30
  • 52 Week High
  • MBIO $74.50
  • JTAI $315.00
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 29.74
  • JTAI 74.40
  • Support Level
  • MBIO $2.40
  • JTAI $2.35
  • Resistance Level
  • MBIO $3.04
  • JTAI $2.61
  • Average True Range (ATR)
  • MBIO 0.65
  • JTAI 0.42
  • MACD
  • MBIO 0.06
  • JTAI 0.30
  • Stochastic Oscillator
  • MBIO 9.30
  • JTAI 63.22

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.

Share on Social Networks: